<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5998">
  <stage>Registered</stage>
  <submitdate>3/06/2016</submitdate>
  <approvaldate>3/06/2016</approvaldate>
  <nctid>NCT02852330</nctid>
  <trial_identification>
    <studytitle>Intracochlear Potentials: Volta Study</studytitle>
    <scientifictitle>Intracochlear Potentials: Intraoperative and Post-operative Measurement Clinical Investigation</scientifictitle>
    <utrn />
    <trialacronym>CLTD5663</trialacronym>
    <secondaryid>CLTD5663</secondaryid>
    <secondaryid>D830836</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hearing Loss</healthcondition>
    <conditioncode>
      <conditioncode1>Ear</conditioncode1>
      <conditioncode2>Deafness</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - SA16 research software
Treatment: devices - CS19 (1.6.2)

Experimental: Voltage tomography - Voltage tomography measurements will be made with the SA16 research software and CS19 (1.6.2) software during and/or immediately after electrode insertion during cochlear implantation and at scheduled post-operative clinical visits.


Treatment: devices: SA16 research software
Software for measurement of voltage tomography intraoperatively.

Treatment: devices: CS19 (1.6.2)
Software for measurement of voltage tomography post-operatively.

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Voltage tomography data measurement - normative voltage tomography data measurement during and/or immediately after electrode insertion into the cochlea using Surgical Assistant Research Tool (SA16) software</outcome>
      <timepoint>intraoperatively</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Voltage tomography data measurement - normative voltage tomography data measurement at activation (1 month post-surgery), 3 months post-activation and 12 months post-activation using CS19 (1.6.2) software.</outcome>
      <timepoint>post-operatively at device activation (1 month post surgery), 3 months post-activation and 12 months post-activation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Meet current cochlear implant indications at the implanting centre for a Cochlear
             Nucleus CI512, CI422, CI522 or CI532 cochlear implant

          2. Aged 18 years and older at the time of implantation.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Recipient of a Nucleus 24 ABI device

          2. Medical or psychological conditions that contraindicate undergoing general anaesthesia
             or surgery.

          3. Ossification, malformation or any other cochlear anomaly, such as common cavity, that
             might prevent complete insertion of the electrode array, as confirmed by medical
             examination.

          4. Unwillingness or inability of the candidate to comply with all investigational
             requirements.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Basic Science</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>10/07/2017</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>10/07/2019</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>The Hearing Cooperative Research Centre - Carlton</hospital>
    <hospital>Royal Victorian Eye and Ear Hospital - East Melbourne</hospital>
    <postcode>3053 - Carlton</postcode>
    <postcode>30002 - East Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Cochlear</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>The Hearing Cooperative Research Centre</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Royal Victoria Eye and Ear Hospital</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Collection of normative voltage tomography data during and/or immediately after electrode
      insertion into the cochlea using Surgical Assistant (SA16) research software and
      postoperatively at activation, three and twelve months post-activation with CS19 research
      software in adults who are receiving a Cochlear Nucleus CI512, CI422, CI522 or CI532 cochlear
      implant.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02852330</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Robert Cowan</name>
      <address>The HEARing CRC</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Michelle R Knight, B.Sc.(Hons)., Dip.Aud.</name>
      <address />
      <phone>+61386623110</phone>
      <fax />
      <email>mknight@cochlear.com</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>